Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Commercialization Timeline Change

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Feb 17, 2022 5:06pm

678 Views

Post# 34439757

Commercialization Timeline Change

In the Sep 2021 Corporate Presentation, on the Phase II Timeline page, commercialization is set to begin in mid-2025 and there is a note - Partner with Big Pharma To Commercialize.

In the Feb 7 2022 Corporate Presentation, on the Phase II Timeline page, commercialization is set to begin in January 2023 (11 months from now) and there is no mention of partnering with big pharma.

What has changed in the last 5 months?

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”